| 000 | 01321 a2200397 4500 | ||
|---|---|---|---|
| 005 | 20250517011326.0 | ||
| 264 | 0 | _c20151019 | |
| 008 | 201510s 0 0 fre d | ||
| 022 | _a0013-7006 | ||
| 024 | 7 |
_a10.1016/S0013-7006(14)70129-0 _2doi |
|
| 040 |
_aNLM _beng _cNLM |
||
| 100 | 1 | _aCermolacce, M | |
| 245 | 0 | 0 |
_a[Affective disorders: endocrine and metabolic comorbidities]. _h[electronic resource] |
| 260 |
_bL'Encephale _cDec 2014 |
||
| 300 |
_aS33-9 p. _bdigital |
||
| 500 | _aPublication Type: Journal Article | ||
| 650 | 0 | 4 |
_aAntipsychotic Agents _xadverse effects |
| 650 | 0 | 4 |
_aCardiovascular Diseases _xdiagnosis |
| 650 | 0 | 4 | _aComorbidity |
| 650 | 0 | 4 | _aCross-Sectional Studies |
| 650 | 0 | 4 |
_aDiabetes Mellitus, Type 1 _xdiagnosis |
| 650 | 0 | 4 |
_aDiabetes Mellitus, Type 2 _xdiagnosis |
| 650 | 0 | 4 | _aHumans |
| 650 | 0 | 4 | _aIatrogenic Disease |
| 650 | 0 | 4 |
_aMetabolic Syndrome _xdiagnosis |
| 650 | 0 | 4 |
_aMood Disorders _xdiagnosis |
| 650 | 0 | 4 |
_aObesity _xdiagnosis |
| 650 | 0 | 4 | _aPrognosis |
| 650 | 0 | 4 | _aRisk Factors |
| 650 | 0 | 4 |
_aThyroid Diseases _xdiagnosis |
| 700 | 1 | _aBelzeaux, R | |
| 700 | 1 | _aAdida, M | |
| 700 | 1 | _aAzorin, J-M | |
| 773 | 0 |
_tL'Encephale _gvol. 40 Suppl 3 _gp. S33-9 |
|
| 856 | 4 | 0 |
_uhttps://doi.org/10.1016/S0013-7006(14)70129-0 _zAvailable from publisher's website |
| 999 |
_c24497686 _d24497686 |
||